The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.Ian evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that the mesenteric occlusion and ischemia is unconfirmed.This is not consistent with the reported adverse event/incident.The clinical evaluation also shows the procedure related harm identified was an additional surgical procedure (colostomy).Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined with the lack of records and imaging available for review.The final patient status was reported to be discharged after the additional surgical procedure.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: g1,2: contact office- name has been updated.H6 evaluation result codes; remove 3233.H6 evaluation conclusion codes; remove 11.
|